Viking Therapeutics, Inc. : Oppenheimer Raises Target Price to $164 From $138
Viking Therapeutics, Inc.:Oppenheimer將目標價從$138上調至$164
Viking Therapeutics, Inc. : Oppenheimer Raises Target Price to $164 From $138
Viking Therapeutics, Inc.:Oppenheimer將目標價從$138上調至$164
譯文內容由第三人軟體翻譯。